
Burning Rock Biotech Ltd — Investor Relations & Filings
Burning Rock Biotech Ltd. is a global diagnostics company specializing in precision oncology. The company focuses on applying next-generation sequencing (NGS) technology to develop and commercialize solutions for cancer diagnostics. Its portfolio includes NGS-based assays for both tissue and liquid biopsies, designed for cancer therapy selection and early detection. Burning Rock offers solutions covering the entire precision oncology development cycle, supported by an in-house database to facilitate clinical trials and research.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 20-F - Burning Rock Biotech Ltd (0001792267) (Filer) | 2026-04-28 | English | |
| 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-19 | English | |
| 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-17 | English | |
| 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-17 | English | |
| 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-17 | English | |
| 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-17 | English |
Browse filings by year
8 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 37943682 | 20-F - Burning Rock Biotech Ltd (0001792267) (Filer) | 2026-04-28 | English | ||
| 32981146 | 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-19 | English | ||
| 32964898 | 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-17 | English | ||
| 32964752 | 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-17 | English | ||
| 32964743 | 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-17 | English | ||
| 32964729 | 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-17 | English | ||
| 32964721 | 3 - Burning Rock Biotech Ltd (0001792267) (Issuer) | 2026-03-17 | English | ||
|
2025
8 filings
| |||||
| 13213432 | FORM 6-K | 2025-12-23 | English | ||
| 13213433 | Major Shareholding Notification 2025 | 2025-12-19 | English | ||
| 13213434 | FORM 6-K | 2025-12-01 | English | ||
| 13213435 | FORM 6-K | 2025-11-20 | English | ||
| 13213436 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 13213437 | FORM 6-K | 2025-09-08 | English | ||
| 13213438 | FORM 6-K | 2025-06-06 | English | ||
| 13213439 | FORM 20-F | 2025-04-29 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
DELTA GOLD TECHNOLOGIES LIMITED
Develops and licenses IP for the quantum computing sector u…
|
DGQ | GB | Professional, scientific and te… |
|
DG INNOVATE PLC
Develops sustainable technologies for electric mobility and…
|
DGI | GB | Professional, scientific and te… |
|
Dianthus Therapeutics, Inc. /DE/
Clinical-stage biotech developing therapies for severe auto…
|
DNTH | US | Professional, scientific and te… |
|
DIMERIX LIMITED
Develops GPCR-targeted therapies for inflammatory kidney an…
|
DXB | AU | Professional, scientific and te… |
|
Dogwood Therapeutics, Inc.
A biotech company developing novel therapeutics for pain an…
|
DWTX | US | Professional, scientific and te… |
|
DORSAVI LTD
Develops clinical-grade wearable sensors and software for h…
|
DVL | AU | Professional, scientific and te… |
|
DreamCIS INC.
Contract research organization for pharma, biotech, and med…
|
223250 | KR | Professional, scientific and te… |
|
DT&CRO CO., Ltd.
A full-service CRO providing non-clinical and clinical stud…
|
383930 | KR | Professional, scientific and te… |
|
Dundee Sustainable Technologies Inc.
Develops proprietary, sustainable metallurgical processes f…
|
DST | CA | Professional, scientific and te… |
|
D.Western Therapeutics Institute, Inc.
Biotechnology firm developing drugs from a proprietary prot…
|
4576 | JP | Professional, scientific and te… |
Burning Rock Biotech Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34185/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34185 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34185 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34185 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34185}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Burning Rock Biotech Ltd (id: 34185)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.